Keyphrases
Heart Failure
100%
Hemodynamic Effects
77%
Hypothyroidism
75%
Questionaire
37%
Disease Symptoms
37%
Hypothyroid
37%
Hyperbilirubinemia
25%
Inotropes
25%
Sheep
25%
Randomized Placebo-controlled Trial
25%
Metalloprotease
25%
Endothelin-1 (ET-1)
25%
Placebo
25%
Dubin-Johnson Syndrome
25%
Neutral Endopeptidase
16%
Afterload Reduction
16%
Acute Decompensated Heart Failure
14%
Genetic Strain
12%
Inotropic Effect
12%
Symptom Assessment
12%
Semen
12%
Male Gamete
12%
Corriedale Sheep
12%
Cryoprotective Effect
12%
Corriedale
12%
Plasma Drug Concentration
12%
Sample Size Requirements
12%
Load Reduction
12%
Sinus Node
12%
Automaticity
12%
Research Animals
12%
Pump Dysfunction
12%
Hormone Supplementation
12%
Long-term Availability
12%
Controlled Mating
12%
Extender
12%
Liver Pathophysiology
12%
Compound A
12%
Vasodilatation
12%
Vasoreactivity
12%
New Therapies
12%
Control Evaluation
12%
Metabolic Disorders
12%
Phosphodiesterase Inhibitors
12%
Single Oral Dose
10%
Oral Therapy
8%
Bradykinin
8%
Functional Status
8%
Tolerability
8%
Angiotensin-converting Enzyme
8%
Randomized Double-blind Trial
8%
Renal Blood Flow
8%
Brain Natriuretic Peptide
8%
Vasodilation
8%
Vasodilatory
8%
Antiproliferative Activity
8%
Hydrolysis
8%
Enzymatic Degradation
8%
Natriuresis
8%
ETB Receptor
8%
Once-daily
8%
Selective Inhibition
8%
Dual Inhibition
8%
Diuretics
8%
Tissue Inhibitor of metalloproteinase-1 (TIMP-1)
8%
Failing Heart
8%
Atrial Natriuretic Peptide
8%
Vascular Smooth muscle Cells
6%
ETA Receptor
6%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
100%
Toborinone
50%
Omapatrilat
50%
Hyperbilirubinemia
25%
Metalloproteinase
25%
Placebo
25%
Corriedale Sheep
25%
Bms 193884
25%
Thyroid Hormone
25%
Endothelin
25%
Dubin Johnson Syndrome
25%
Membrane Metalloendopeptidase
16%
Endothelin 1
15%
Heart Ventricle Remodeling
12%
Metabolic Disorder
12%
Myosin Heavy Chain
12%
Pathophysiology
12%
Liotrix
12%
Beta Adrenergic Receptor
12%
Heart Left Ventricle Failure
12%
Tolerability
8%
Bradykinin
8%
Dipeptidyl Carboxypeptidase
8%
Atrial Natriuretic Factor
8%
Diuretic Agent
8%
Metalloproteinase Inhibitor
8%
Brain Natriuretic Peptide
8%
Functional Status
8%
Inotropic Agent
6%
Amino Acid
6%
Drug Concentration
6%
Endothelin 2
6%
Placebo-Controlled Study
6%
Phosphodiesterase Inhibitor
6%
Medicine and Dentistry
Bms 193884
50%
Heart Failure
25%
Endothelin
25%
Placebo
25%
Endothelin 1
15%
Myocardium
6%
Endothelin 2
6%
Amino Acid
6%
Vascular Smooth Muscle Cell
6%